[Current developments and perspectives in targeted therapies].


Many different approaches for improving the prognosis of patients with advanced non-small-cell lung cancer (NSCLC) are currently being investigated. This article discusses the significance of maintenance therapy after primary chemotherapy and reviews study data on second-generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs… (More)
DOI: 10.1159/000313971


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics